Summary of Duties:
The Drug Development Institute (DDI) is a biotech-like institute embedded in The Ohio State University Comprehensive Cancer Center ̶ James Cancer Hospital and Solove Research Institute. The DDI’s goal is to rapidly translate Ohio State’s most innovative research into tomorrow’s most promising treatments for patients with cancer. The Drug Discovery Professional will function as an expert in cancer discovery research with an emphasis on discovery and preclinical development. Though basic research experience in drug discovery and development is very important for this role, the Drug Discovery Professional is not a laboratory based position. Rather, the responsibilities are a balance of scientific strategy and execution, administrative efforts, and business development aimed at partnership with industry to enable clinical development of novel therapeutics.
- Work with investigators and project teams to develop strategies to advance pre-clinical projects toward IND enabling studies, IND filing, or Phase I clinical trials
- Development of milestones and budgets that map to project plans with Go/No-Go decisions that define and guide project advancement
- Collaborate with project scientists to design experiments for achieving project milestones
- Evaluate potential projects for inclusion into DDI portfolio – criteria for probability of success include scientific merit, unmet medical need, intellectual property, competitive landscape
- All activities are expected to be developed and executed in close collaboration as a team with DDI colleagues and project scientists
- Support and advise on patent filings
- Manage project teams to ensure milestones are accomplished in a timely and efficient manner and projects remain on budget
- Prepare executive summaries for senior leadership
- Prepare project overviews and in depth reviews and present to our scientific advisory board
- Communicate DDI projects and mission to a diverse set of audiences, both technical and non-technical, scientific and business
- Facilitate and participate in outreach within the university to build understanding of the drug discovery and development process and to search for new projects for the DDI
Business Development Responsibilities:
- Build relationships and contacts with pharma, venture capital, and other investors
- Design and present non-confidential project summaries and technical briefs to be presented to pharma, venture capital, and other investors
- Work with Technology Commercialization Office and patent counsel to protect OSU inventions
- Work with Technology Commercialization Office to identify potential licensing partners for DDI projects
- Support Technology Commercialization Office efforts to license inventions associated with DDI projects
Doctorate degree (MD, PhD, Pharm.D) with drug discovery experience. Pharmaceutical industry experience strongly preferred. Candidates with early phase drug discovery and development experience working in cross-functional teams, including those with business development background are encouraged to apply. Specialization in Cancer Biology, Cancer Immunology, Pharmacology, or In vitro / biochemical assays preferred.
The Ohio State University offers a competitive salary, outstanding benefits, participation in workshops and conferences, high quality Shared Resources, and many opportunities for continued professional development.
Qualified candidates should submit their current curriculum vitae to Jeffrey.Patrick@osumc.edu.
The Ohio State University is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation or identity, national origin, disability status, or protected veteran status.
One of only 49 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers, the OSUCCC – James has more than 330 cancer researchers who represent 11 of the university’s 15 colleges and work closely with nearly 200 oncology subspecialists in a “precision cancer medicine” model that uses genomic technologies to aid the diagnosis and treatment of each patient’ s biologically unique cancer. The OSUCCC – James also is one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI.